Maker of Narcan Nasal Spray Plans to Sell Overdose Antidote for Less Than $50

FRIDAY, April 21, 2023 (HealthDay News) -- The company that makes the opioid overdose nasal spray Narcan plans to have it available in pharmacies and online by late summer for a price of less than $50.
Emergent sent a response letter Thursday to Sen. Richard Blumenthal of Connecticut, who had sent a letter to the company earlier this month asking about "the affordable OTC [over-the-counter] Narcan list price that your company intends to set."
"A goal for the out-of-pocket retailer price is to be consistent with our public interest pricing … although retail price is set by individual retailers," Emergent said in a statement.
Pricing is currently less than $50, on average, for a kit that contains two 4-mg doses, when purchased by government agencies, nonprofits, and first responders. The wholesale price is $125.
"Currently, your product is reported as having a wholesale price as high as $120 for two doses, with significant variation in price, depending on location and insurance coverage. Individuals without insurance -- about one-fifth of people with opioid use disorder are uninsured -- will be forced to bear the full cost," Blumenthal wrote in his letter to the company. "I ask you to commit to work with public health experts, addiction specialists, and community activists to develop and determine a list price for OTC Narcan that makes it affordable and accessible for those who need it most."
The U.S. Food and Drug Administration approved OTC Narcan nasal spray last month to be sold without a prescription. Retail pharmacies dispensed about 1.2 million prescriptions of naloxone in 2021, according to the American Medical Association.
Continued federal funding for substance abuse treatment and prevention programs, with initiatives that distribute Narcan, are important, Emergent said in its letter. The company also noted the importance of private insurers, Medicare, and Medicaid covering Narcan.
Nearly 1 million people have died in the past 20 years from drug overdose, many from opioids, according to the U.S. Centers for Disease Control and Prevention.
Related Posts
Third, Fourth COVID-19 Vaccine Doses Boost Humoral Response in Seniors
WEDNESDAY, July 27, 2022 (HealthDay News) -- Third and fourth BNT162b2 vaccine...
Los niños vuelven a la escuela, y una encuesta halla que un 71 por ciento tuvieron problemas el año pasado
VIERNES, 28 de julio de 2023 (HealthDay News) -- Mientras los niños se preparan...
ASCO: Black Patients With Metastatic Breast Cancer Willing to Consider Clinical Trials
TUESDAY, June 7, 2022 (HealthDay News) -- Black patients with metastatic breast...
U.S. Monkeypox Cases Are Declining
FRIDAY, Sept. 2, 2022 (HealthDay News) -- While the number of Americans with...
